Literature DB >> 1687219

Histamine, leukotriene D4 and platelet-activating factor in guinea pig passive cutaneous anaphylaxis.

V B Weg1, M L Watson, R S Cordeiro, T J Williams.   

Abstract

The involvement of histamine, leukotriene D4 (LTD4) and platelet-activating factor (PAF) in cutaneous anaphylaxis was investigated in a guinea pig model. When given alone, the H1 receptor antagonist chlorpheniramine, the LTD4/E4 antagonist LY171883 and the PAF antagonist WEB2086 were unable to inhibit increased microvascular plasma protein leakage in passive cutaneous anaphylaxis (PCA) reactions, as monitored by the extravasation of intravenously injected 125I-albumin. Furthermore the H2 receptor antagonist cimetidine and the serotonin antagonist methysergide were unable to reduce PCA responses when given alone or in combination with chlorpheniramine. In marked contrast, combinations of antagonists were able to reduce plasma leakage significantly. A combination of chlorpheniramine, LY171883 and WEB2086 virtually abolished plasma leakage during the PCA response, but did not influence the plasma protein leakage induced by intradermal injection of bradykinin. These results demonstrate that these allergic reactions involve several mediators and that the inability of an individual mediator antagonist to reduce responses does not necessarily rule out a role for that mediator.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1687219     DOI: 10.1016/0014-2999(91)90700-z

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  17 in total

Review 1.  The enzymology and pharmacology of 5-lipoxygenase and 5-lipoxygenase activating protein.

Authors:  R L Bell; R R Harris
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

2.  A comparison of the inhibitory activity of PDE4 inhibitors on leukocyte PDE4 activity in vitro and eosinophil trafficking in vivo.

Authors:  N Cooper; M M Teixeira; J Warneck; J M Miotla; R E Wills; D M Macari; R W Gristwood; P G Hellewell
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

3.  Effect of a 5-lipoxygenase inhibitor, ZM 230487, on cutaneous allergic inflammation in the guinea-pig.

Authors:  M M Teixeira; P G Hellewell
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

4.  Immediate inhibitory effect of methylprednisolone suleptanate (U-67590A) on antigen-induced cutaneous and airway anaphylactic responses in guinea-pigs.

Authors:  M Hashimoto; Y Shinozaki; M Katori
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

5.  Effects of phosphodiesterase isoenzyme inhibitors on cutaneous inflammation in the guinea-pig.

Authors:  M M Teixeira; A G Rossi; T J Williams; P G Hellewell
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

6.  Drug modulation of antigen-induced paw oedema in guinea-pigs: effects of lipopolysaccharide, tumour necrosis factor and leucocyte depletion.

Authors:  J I da Motta; F Q Cunha; B B Vargaftig; S H Ferreira
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

7.  Role of prostaglandins and nitric oxide in acute inflammatory reactions in guinea-pig skin.

Authors:  M M Teixeira; T J Williams; P G Hellewell
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

8.  Suppression by intradermal administration of heparin of eosinophil accumulation but not oedema formation in inflammatory reactions in guinea-pig skin.

Authors:  M M Teixeira; P G Hellewell
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

9.  E-type prostaglandins enhance local oedema formation and neutrophil accumulation but suppress eosinophil accumulation in guinea-pig skin.

Authors:  M M Teixeira; T J Williams; P G Hellewell
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

10.  Inflammatory mechanisms in the passive cutaneous anaphylactic reaction in the rabbit: evidence that novel mediators are involved.

Authors:  P G Hellewell; P J Jose; T J Williams
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.